Alcoholism  >>  aticaprant (JNJ-67953964)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aticaprant (JNJ-67953964) / J&J
NCT01232439: A Study of Brain Receptor Occupancy in Healthy Subjects

Completed
1
13
US
opioid receptor kappa antagonist, LY2456302
Eli Lilly and Company
Alcohol Dependence
04/11
04/11

Download Options